Pubblicazioni

Screening for type 1 diabetes genetic risk in newborns of continental Italy. Primary prevention (Prevefin Italy)–preliminary data.
Lorini R, Minicucci L, Napoli F, Padovani P, Bazzigaluppi E, Tortoioli C, Cherubini V, Bottazzo G, Pozzilli P, Falorni A, Buzzetti R.
Acta Biomed. 2005;76 Suppl 3:31-5.PMID: 16915793 Clinical Trial. No abstract available.

Residual insulin secretion at diagnosis of type 1 diabetes is independently associated with both, age of onset and HLA genotype.
Petrone A, Galgani A, Spoletini M, Alemanno I, Di Cola S, Bassotti G, Picardi A, Manfrini S, Osborn J, Pozzilli P, Buzzetti R.
Diabetes Metab Res Rev. 2005 May-Jun;21(3):271-5. doi: 10.1002/dmrr.549.PMID: 15786423

10.1515/jpem.2005.18.8.749.PMID: 16200840 Clinical Trial.

Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study.
Pozzilli P, Manfrini S, Buzzetti R, Lampeter E, Leeuw ID, Iafusco D, Prisco M, Ionescu-Tirgoviste C, Kolouskovà S, Linn T, Ludvigsson J, Madàcsy L, Mrozikiewicz AS, Mrozikiewicz PM, Podar T, Vavrinec J, Vialettes B, Visalli N, Yilmaz T, Browne PD; IMDIAB group.
Diabetes Res Clin Pract. 2005 Jun;68(3):258-64. doi: 10.1016/j.diabres.2004.10.001. Epub 2004 Nov 21.PMID: 15936469

Biokinetics of buccal spray insulin in patients with type 1 diabetes.
Pozzilli P, Manfrini S, Costanza F, Coppolino G, Cavallo MG, Fioriti E, Modi P.
Metabolism. 2005 Jul;54(7):930-4. doi: 10.1016/j.metabol.2005.02.008.PMID: 15988703

A two year observational study of nicotinamide and intensive insulin therapy in patients with recent onset type 1 diabetes mellitus.
Crinó A, Schiaffini R, Ciampalini P, Suraci MC, Manfrini S, Visalli N, Matteoli MC, Patera P, Buzzetti R, Guglielmi C, Spera S, Costanza F, Fioriti E, Pitocco D, Pozzilli P; IMDIAB Group.
J Pediatr Endocrinol Metab. 2005 Aug;18(8):749-54. doi:

Clinical phenotype and beta-cell autoimmunity in Italian patients with adult-onset diabetes.
Genovese S, Bazzigaluppi E, Gonçalves D, Ciucci A, Cavallo MG, Purrello F, Anello M, Rotella CM, Bardini G, Vaccaro O, Riccardi G, Travaglini P, Morenghi E, Bosi E, Pozzilli P.
Eur J Endocrinol. 2006 Mar;154(3):441-7.

Clinical review: Type 1 diabetes and latent autoimmune diabetes in adults: one end of the rainbow.
Leslie RD, Williams R, Pozzilli P.
J Clin Endocrinol Metab. 2006 May;91(5):1654-9.

Exercise training can modify the natural history of diabetic peripheral neuropathy.
Balducci S, Iacobellis G, Parisi L, Di Biase N, Calandriello E, Leonetti F, Fallucca F.
J Diabetes Complications. 2006 Jul-Aug;20(4):216-23.

The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI).
Pitocco D, Crinò A, Di Stasio E, Manfrini S, Guglielmi C, Spera S, Anguissola GB, Visalli N, Suraci C, Matteoli MC, Patera IP, Cavallo MG, Bizzarri C, Pozzilli P; IMDIAB Group.
Diabet Med. 2006 Aug;23(8):920-3.

Blood ketone bodies in patients with recent-onset type 1 diabetes (a multicenter study).
Prisco F, Picardi A, Iafusco D, Lorini R, Minicucci L, Martinucci ME, Toni S, Cerutti F, Rabbone I, Buzzetti R, Crino A, Pozzilli P.
Pediatr Diabetes. 2006 Aug;7(4):223-8.

Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetes.
Picardi A, Visalli N, Lauria A, Suraci C, Buzzetti R, Merola MK, Manfrini S, Guglielmi C, Gentilucci UV, Pitocco D, Crinò A, Bizzarri C, Cappa M, Pozzilli P.
Horm Metab Res. 2006 Oct;38(10):668-72.

Suppression of human T-cell responses to beta-cells by activation of B7-H4 pathway.
Ou D, Wang X, Metzger DL, Ao Z, Pozzilli P, James RF, Chen L, Warnock GL.
Cell Transplant. 2006;15(5):399-410.

Use of repaglinide during the first weeks of pregnancy in two type 2 diabetic women.
Napoli A, Ciampa F, Colatrella A, Fallucca F.
Diabetes Care. 2006 Oct;29(10):2326-7.

Polymorphisms of insulin receptor substrate 1 and beta3-adrenergic receptor genes in gestational diabetes and normal pregnancy.
Fallucca F, Dalfrà MG, Sciullo E, Masin M, Buongiorno AM, Napoli A, Fedele D, Lapolla A. Metabolism. 2006 Nov;55(11):1451-6.

A new expression of diabetes: double diabetes.
Pozzilli P, Buzzetti R.
Trends Endocrinol Metab. 2007 Mar;18(2):52-7.

Raised C-reactive protein levels in patients with recent onset type 1 diabetes.
Picardi A, Valorani MG, Vespasiani Gentilucci U, Manfrini S, Ciofini O, Cappa M, Guglielmi C, Pozzilli P; IMDIAB Group.
Diabetes Metab Res Rev. 2007 Mar;23(3):211-4.

Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis: response to Snowling and Hopkins.
Balducci S, Alessi E, Cardelli P, Cavallo S, Fallucca F, Pugliese G.
Diabetes Care. 2007 Apr;30(4):e25; author reply e26.

Immuno-intervention and preservation of beta-cell function in type 1 diabetes.
Pozzilli P.
Diabetes Metab Res Rev. 2007 May;23(4):255-6.

The loss of entropy circadian rhythm in sinusal R-R intervals of type 1 diabetic pregnant women suggests an indeterministic chaos in cardiac pacing (minimum delirium cordis syndrome). A newly identifiable type of silent cardiac dysautonomia?
Cugini P, Curione M, Castro C, Napoli A, Francia P, Colatrella A, Di Bona S, Cammarota C, Cardarelli G, Amato S, Fallucca F.
Acta Cardiol. 2007 Jun;62(3):257-64.

Plasma levels of adrenomedullin, a vasoactive peptide, in type 2 diabetic patients with and without retinopathy.
Caliumi C, Balducci S, Petramala L, Cotesta D, Zinnamosca L, Cianci R, Di Donato D, Vingolo EM, Fallucca F, Letizia C.
Minerva Endocrinol. 2007 Jun;32(2):73-8.

Length of gestation and gender are associated with HLA genotypes at risk for Type 1 diabetes (Italian DIABFIN 3).
Locatelli M, Buzzetti R, Galgani A, Montemari AL, Khazrai M, Petrone A, Visalli N, Meschi F, Minicucci L, Lorini R, Cristaldi A, Valorani MG, Bottazzo GF, Pozzilli P; DIABFIN Study Group. Diabet Med. 2007 Aug;24(8):916-9.

Double or hybrid diabetes associated with an increase in type 1 and type 2 diabetes in children and youths.
Pozzilli P, Guglielmi C, Pronina E, Petraikina E.
Pediatr Diabetes. 2007 Dec;8 Suppl 9:88-95.

Low-risk HLA genotype in Type 1 diabetes is associated with less destruction of pancreatic B-cells 12 months after diagnosis.
Spoletini M, Petrone A, Zampetti S, Capizzi M, Zavarella S, Osborn J, Foffi C, Tuccinardi D, Pozzilli P, Buzzetti R; IMDIAB Group.
Diabet Med. 2007 Dec;24(12):1487-90.

Effects of maternal diabetes on visual evoked potentials and early psychomotor development of the offspring.
Brinciotti M, Matricardi M, Colatrella A, Torcia F, Fallucca F, Napoli A.
Diabetes Care. 2007 Dec;30(12):e128.

Age at diagnosis of type 1 diabetes and the effect of immunomodulatory therapies on residual beta cell function.
Pitocco D, DiStasio E, Crinò A, Manfrini S, Guglielmi C, Visalli N, Suraci C, Matteoli MC, Cavallo MG, Bizzarri C, Pozzilli P; IMDIAB Group.
Horm Metab Res. 2008 Jan;40(1):66-8.

Pancreatic scintigraphy with 99mTc-interleukin-2 at diagnosis of type 1 diabetes and after 1 year of nicotinamide therapy.
Chianelli M, Parisella MG, Visalli N, Mather SJ, D’Alessandria C, Pozzilli P, Signore A; IMDIAB study group.
Diabetes Metab Res Rev. 2008 Feb;24(2):115-22.

Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults.
Brophy S, Yderstraede K, Mauricio D, Hunter S, Hawa M, Pozzilli P, Schernthaner G, Schloot N, Buzzetti R, Davies H, Leslie D, Williams R; Action LADA Group.
Diabetes Care. 2008 Mar;31(3):439-41.

The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3.
Petrone A, Suraci C, Capizzi M, Giaccari A, Bosi E, Tiberti C, Cossu E, Pozzilli P, Falorni A, Buzzetti R; NIRAD Study Group.
Diabetes Care. 2008 Mar;31(3):534-8.

Type 1 diabetes risk for human leukocyte antigen (HLA)-DR3 haplotypes depends on genotypic context: association of DPB1 and HLA class I loci among DR3- and DR4-matched Italian patients and controls.
Noble JA, Martin A, Valdes AM, Lane JA, Galgani A, Petrone A, Lorini R, Pozzilli P, Buzzetti R, Erlich HA.
Hum Immunol. 2008 Apr-May;69(4-5):291-300.

Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies.
Cardwell CR, Stene LC, Joner G, Cinek O, Svensson J, Goldacre MJ, Parslow RC, Pozzilli P, Brigis G, Stoyanov D, Urbonaite B, Sipetić S, Schober E, Ionescu-Tirgoviste C, Devoti G, de Beaufort CE, Buschard K, Patterson CC.
Diabetologia. 2008 May;51(5):726-35.

The PTPN22 1858T gene variant in type 1 diabetes is associated with reduced residual beta-cell function and worse metabolic control.
Petrone A, Spoletini M, Zampetti S, Capizzi M, Zavarella S, Osborn J, Pozzilli P, Buzzetti R; Immunotherapy Diabetes (IMDIAB) Group. Diabetes Care. 2008 Jun;31(6):1214-8.

Antinuclear antibodies prevalence in Filipinos migrated to Italy.
Cacciapaglia F, Arcarese L, Rigon A, Vadacca M, Valorani MG, Pozzilli P, Afeltra A.
Eur Rev Med Pharmacol Sci. 2008 Jul-Aug;12(4):267-70.

A 10-year (1996-2005) prospective study of the incidence of Type 1 diabetes in Moscow in the age group 0-14 years.
Pronina EA, Petraikina EE, Antsiferov MB, Duchareva OV, Petrone A, Buzzetti R, Pozzilli P.
Diabet Med. 2008 Aug;25(8):956-9.

Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes.
Greenbaum CJ, Mandrup-Poulsen T, McGee PF, Battelino T, Haastert B, Ludvigsson J, Pozzilli P, Lachin JM, Kolb H; Type 1 Diabetes Trial Net Research Group; European C-Peptide Trial Study Group.
Diabetes Care. 2008 Oct;31(10):1966-71.

Diabetes classification: grey zones, sound and smoke: Action LADA 1.
Leslie RD, Kolb H, Schloot NC, Buzzetti R, Mauricio D, De Leiva A, Yderstraede K, Sarti C, Thivolet C, Hadden D, Hunter S, Schernthaner G, Scherbaum W, Williams R, Pozzilli P.
Diabetes Metab Res Rev. 2008 Oct;24(7):511-9.

The Italian Diabetes and Exercise Study (IDES): design and methods for a prospective Italian multicentre trial of intensive lifestyle intervention in people with type 2 diabetes and the metabolic syndrome.
Balducci S, Zanuso S, Massarini M, Corigliano G, Nicolucci A, Missori S, Cavallo S, Cardelli P, Alessi E, Pugliese G, Fallucca F; Italian Diabetes Exercise Study (IDES) Group.
Nutr Metab Cardiovasc Dis. 2008 Nov;18(9):585-95.

New potential treatments for protection of pancreatic B-cell function in Type 1 diabetes.
Cernea S, Pozzilli P.
Diabet Med. 2008 Nov;25(11):1259-67.

Endothelial progenitor cells and their potential therapeutic applications.
Khoo CP, Pozzilli P, Alison MR.
Regen Med. 2008 Nov;3(6):863-76.

Metabolic syndrome and autoimmune diabetes: action LADA 3.
Hawa MI, Thivolet C, Mauricio D, Alemanno I, Cipponeri E, Collier D, Hunter S, Buzzetti R, de Leiva A, Pozzilli P, Leslie RD; Action LADA Group.
Diabetes Care. 2009 Jan;32(1):160-4.

Visual evoked potentials in infants of diabetic mothers: relations to clinical and metabolic status during pregnancy and delivery.
Brinciotti M, Matricardi M, Colatrella A, Torcia F, Fallucca F, Napoli A.
Clin Neurophysiol. 2009 Mar;120(3):563-8.

New prospects for immunotherapy at diagnosis of type 1 diabetes.
Pozzilli P, Leslie RD.
Diabetes Metab Res Rev. 2009 May;25(4):299-301.

Physical exercise, public health and quality of life in diabetes.
Fallucca F, Pozzilli P.
Diabetes Metab Res Rev. 2009 Sep;25 Suppl 1:S1-3.

Physical activity/exercise training in type 2 diabetes. The role of the Italian Diabetes and Exercise Study.
Balducci S, Zanuso S, Fernando F, Fallucca S, Fallucca F, Pugliese G; Italian Diabetes Exercise Study (IDES) Group.
Diabetes Metab Res Rev. 2009 Sep;25 Suppl 1:S29-33.

Hypertensive disorders in normal/over-weight and obese type 2 diabetic pregnant women.
Colatrella A, Braucci S, Festa C, Bianchi P, Fallucca F, Mattei L, Trappolini M, Napoli A.
Exp Clin Endocrinol Diabetes. 2009 Sep;117(8):373-7.

Self glucose monitoring and physical exercise in diabetes.
Pugliese G, Zanuso S, Alessi E, Simonelli P, Fallucca S, Fallucca F, Balducci S.
Diabetes Metab Res Rev. 2009 Sep;25 Suppl 1:S11-7.

Challenges in developing endpoints for type 1 diabetes intervention studies.
Cernea S, Raz I, Herold KC, Hirshberg B, Roep BO, Schatz DA, Fleming GA, Pozzilli P, Little R, Schloot NC, Leslie RD, Skyler JS, Palmer JP; D-Cure Workshop.
Diabetes Metab Res Rev. 2009 Nov;25(8):694-704.

Beta-cell protection and therapy for latent autoimmune diabetes in adults.
Cernea S, Buzzetti R, Pozzilli P.
Diabetes Care. 2009 Nov;32 Suppl 2:S246-52.

Double diabetes: a mixture of type 1 and type 2 diabetes in youth.
Pozzilli P, Guglielmi C.
Endocr Dev. 2009;14:151-66.

Unexpectedly high rates of obesity and dysglycemia among villagers in Cameroon.
Napoli N, Mottini G, Arigliani M, Creta A, Giua R, Incammisa A, Carotti S, Sihom F, Yimagou I, Alombah R, Mbanya JC, Pozzilli P.
Diabetes Metab Res Rev. 2010 Jan;26(1):10-2.

Review of clinical trials: update on oral insulin spray formulation.
Pozzilli P, Raskin P, Parkin CG.
Diabetes Obes Metab. 2010 Feb;12(2):91-6.

Maternal age at birth and childhood type 1 diabetes: a pooled analysis of 30 observational studies.
Cardwell CR, Stene LC, Joner G, Bulsara MK, Cinek O, Rosenbauer J, Ludvigsson J, Jané M, Svensson J, Goldacre MJ, Waldhoer T, Jarosz-Chobot P, Gimeno SG, Chuang LM, Parslow RC, Wadsworth EJ, Chetwynd A, Pozzilli P, Brigis G, Urbonaite B, Sipetic S, Schober E, Devoti G, Ionescu-Tirgoviste C, de Beaufort CE, Stoyanov D, Buschard K, Patterson CC.
Diabetes. 2010 Feb;59(2):486-94.

Birthweight and the risk of childhood-onset type 1 diabetes: a meta-analysis of observational studies using individual patient data.
Cardwell CR, Stene LC, Joner G, Davis EA, Cinek O, Rosenbauer J, Ludvigsson J, Castell C, Svensson J, Goldacre MJ, Waldhoer T, Polanska J, Gimeno SG, Chuang LM, Parslow RC, Wadsworth EJ, Chetwynd A, Pozzilli P, Brigis G, Urbonaite B, Sipetić S, Schober E, Ionescu-Tirgoviste C, de Beaufort CE, Stoyanov D, Buschard K, Patterson CC.
Diabetologia. 2010 Apr;53(4):641-51.

Quality of diet and potential renal acid load as risk factors for reduced bone density in elderly women.
Pedone C, Napoli N, Pozzilli P, Lauretani F, Bandinelli S, Ferrucci L, Antonelli-Incalzi R.
Bone. 2010 Apr;46(4):1063-7. doi: 10.1016/j.bone.2009.11.031. Epub 2009 Dec 11.

The A1C and ABCD of glycaemia management in type 2 diabetes: a physician’s personalized approach.
Pozzilli P, Leslie RD, Chan J, De Fronzo R, Monnier L, Raz I, Del Prato S.
Diabetes Metab Res Rev. 2010 May;26(4):239-44.

Computer use, free time activities and metabolic control in patients with type 1 diabetes.
Benevento D, Bizzarri C, Pitocco D, Crinò A, Moretti C, Spera S, Tubili C, Costanza F, Maurizi A, Cipolloni L, Cappa M, Pozzilli P; IMDIAB Group.
Diabetes Res Clin Pract. 2010 Jun;88(3):e32-4.

Association of TCF7L2 gene variants with low GAD autoantibody titre in LADA subjects (NIRAD Study 5).
Zampetti S, Spoletini M, Petrone A, Capizzi M, Arpi ML, Tiberti C, Di Pietro S, Bosi E, Pozzilli P, Giorgino F, Buzzetti R; Nirad Study Group.
Diabet Med. 2010 Jun;27(6):701-4.

No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial.
Bizzarri C, Pitocco D, Napoli N, Di Stasio E, Maggi D, Manfrini S, Suraci C, Cavallo MG, Cappa M, Ghirlanda G, Pozzilli P; IMDIAB Group.
Diabetes Care. 2010 Sep;33(9):1962-3.

Age-period-cohort analysis of 1990-2003 incidence time trends of childhood diabetes in Italy: the RIDI study.
Bruno G, Maule M, Merletti F, Novelli G, Falorni A, Iannilli A, Iughetti L, Altobelli E, d’Annunzio G, Piffer S, Pozzilli P, Iafusco D, Songini M, Roncarolo F, Toni S, Carle F, Cherubini V; RIDI Study Group.
Diabetes. 2010 Sep;59(9):2281-7.

Incidence of severe nocturnal hypoglycemia in patients with type 1 diabetes treated with insulin lispro or regular human insulin in addition to basal insulin glargine.
Brunetti P, Muggeo M, Cattin L, Arcangeli A, Pozzilli P, Provenzano V, Francesconi A, Calatola P, Santeusanio F.
Nutr Metab Cardiovasc Dis. 2010 Sep;20(7):519-26.

Hypoxia increases Sca-1/CD44 co-expression in murine mesenchymal stem cells and enhances their adipogenic differentiation potential.
Valorani MG, Germani A, Otto WR, Harper L, Biddle A, Khoo CP, Lin WR, Hawa MI, Tropel P, Patrizi MP, Pozzilli P, Alison MR.
Cell Tissue Res. 2010 Jul;341(1):111-20. doi: 10.1007/s00441-010-0982-8. Epub 2010 May 23.PMID: 20496083 IF 4.061

Incidence of new fractures in women with osteoporosis-induced vertebral fractures detected on routine lateral chest radiographs.
Occhicone F, Quattrocchi CC, Napoli N, Dell’Aia P, D’Agostino F, Pozzilli P, Beomonte Zobel B.
Radiol Med. 2010 Aug;115(5):815-25. doi: 10.1007/s11547-010-0564-6. Epub 2010 Jun 24.PMID: 20577909 IF 6.313

Incidence of type 1 diabetes has doubled in Rome and the Lazio region in the 0- to 14-year age-group: a 6-year prospective study (2004-2009).
Bizzarri C, Patera PI, Arnaldi C, Petrucci S, Bitti ML, Scrocca R, Manfrini S, Portuesi R, Buzzetti R, Cappa M, Pozzilli P; Immunotherapy Diabetes (IMDIAB) Group.
Diabetes Care. 2010 Nov;33(11):e140. doi: 10.2337/dc10-1168.PMID: 20980419 No abstract available. IF 17.155

Circulating Reg1α proteins and autoantibodies to Reg1α proteins as biomarkers of β-cell regeneration and damage in type 1 diabetes.
Astorri E, Guglielmi C, Bombardieri M, Alessandri C, Buzzetti R, Maggi D, Valesini G, Pitzalis C, Pozzilli P.
Horm Metab Res. 2010 Dec;42(13):955-60. doi: 10.1055/s-0030-1267206. Epub 2010 Oct 22.PMID: 20972946 IF 2.936

Adiponectin and bone mass density: The InCHIANTI study.
Napoli N, Pedone C, Pozzilli P, Lauretani F, Ferrucci L, Incalzi RA.
Bone. 2010 Dec;47(6):1001-5. doi: 10.1016/j.bone.2010.08.010. Epub 2010 Sep 6.PMID: 20804877 IF 4.626

Blood glucose monitoring in the normal population: the PREDICA study.
Napoli N, Costanza F, Di Stasio E, Strollo R, Manfrini S, Cipponeri E, Picardi A, Carrano F, Dell’Anna V, Macino W, Pozzilli P.
Acta Diabetol. 2011 Mar;48(1):29-34. doi: 10.1007/s00592-010-0212-6. Epub 2010 Aug 12.PMID: 20703502  IF 4.087

Improvement of quality of life with supervised exercise training in subjects with type 2 diabetes mellitus.
Nicolucci A, Balducci S, Cardelli P, Zanuso S, Pugliese G; Fallucca F and the Italian Diabetes Exercise Study (IDES) Investigators.
Arch Intern Med. 2011 Nov 28;171(21):1951-3. IF 11.750

Supervised exercise training counterbalances the adverse effects of insulin therapy in overweight/obese subjects with type 2 diabetes.
Balducci S, Zanuso S, Cardelli P, Salerno G, Fallucca S, Nicolucci A, Pugliese G, Fallucca F and the Italian Diabetes Exercise Study (IDES) Investigators.
Diabetes Care. 2012 Jan;35(1):39-41. IF= 16,02

Changes in physical fitness predict improvements in modifiable cardiovascular risk factors independently of body weight loss in subjects with type 2 diabetes participating in the Italian Diabetes and Exercise Study (IDES).
Balducci S, Zanuso S, Cardelli P, Salvi L, Mazzitelli G, Bazuro A, Iacobini C, Nicolucci A, Pugliese G, Fallucca F and the Italian Diabetes Exercise Study (IDES) Investigators.
Diabetes Care. 2012 Jun;35(6):1347-54. IF= 16,02

HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus.
Strollo R, Rizzo P, Spoletini M, Landy R, Hughes C, Ponchel F, Napoli N, Palermo A, Buzzetti R, Pozzilli P, Nissim A.
Diabetologia. 2013 Mar;56(3):563-72. doi: 10.1007/s00125-012-2780-1. Epub 2012 Nov 19.PMID: 23160643 IF 10.122

Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7.
Hawa MI, Kolb H, Schloot N, Beyan H, Paschou SA, Buzzetti R, Mauricio D, De Leiva A, Yderstraede K, Beck-Neilsen H, Tuomilehto J, Sarti C, Thivolet C, Hadden D, Hunter S, Schernthaner G, Scherbaum WA, Williams R, Brophy S, Pozzilli P, Leslie RD; Action LADA consortium.
Diabetes Care. 2013 Apr;36(4):908-13. doi: 10.2337/dc12-0931. Epub 2012 Dec 17.PMID: 23248199 Free PMC article. IF 17.152

Increasing adiposity is associated with higher adipokine levels and lower bone mineral density in obese older adults.
Aguirre L, Napoli N, Waters D, Qualls C, Villareal DT, Armamento-Villareal R.
J Clin Endocrinol Metab. 2014 Sep;99(9):3290-7. IF 5,605

Antibodies to post-translationally modified insulin in type 1 diabetes.
Strollo R, Vinci C, Arshad MH, Perrett D, Tiberti C, Chiarelli F, Napoli N, Pozzilli P, Nissim A.
Diabetologia. 2015 Dec;58(12):2851-60. IF 7,113

Modulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet.
Candela M, Biagi E, Soverini M, Consolandi C, Quercia S, Severgnini M, Peano C, Turroni S, Rampelli S, Pozzilli P, Pianesi M, Fallucca F, Brigidi P.
Br J Nutr. 2016 Jul;116(1):80-93. IF 3,510

Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children.
Strollo R, Vinci C, Napoli N, Pozzilli P, Ludvigsson J, Nissim A.
Diabetologia. 2017 Aug;60(8):1467-1474. IF 7,113

Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes.
Garg SK, Henry RR, Banks P, Buse JB, Davies MJ, Fulcher GR, Pozzilli P, Gesty-Palmer D, Lapuerta P, Simó R, Danne T, McGuire DK, Kushner JA, Peters A, Strumph P.
N Engl J Med. 2017 Dec 14;377(24):2337-2348. IF 74.699

Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial.
Writing Group for the TRIGR Study Group, Knip M, Åkerblom HK, Al Taji E, Becker D, Bruining J, Castano L, Danne T, de Beaufort C, Dosch HM, Dupre J, Fraser WD, Howard N, Ilonen J, Konrad D, Kordonouri O, Krischer JP, Lawson ML, Ludvigsson J, Madacsy L, Mahon JL, Ormisson A, Palmer JP, Pozzilli P, Savilahti E, Serrano-Rios M, Songini M, Taback S, Vaarala O, White NH, Virtanen SM, Wasikowa R.
JAMA. 2018 Jan 2;319(1):38-48. IF 45.540

Atypical Femur Fractures: Review of Epidemiology, Relationship to Bisphosphonates, Prevention, and Clinical Management.
Black DM, Abrahamsen B, Bouxsein ML, Einhorn T, Napoli N.
Endocr Rev. 2019 Apr 1;40(2):333-368. IF 15.167

The reconstructed natural history of type 1 diabetes mellitus.
Pozzilli P, Signore A.
Nat Rev Endocrinol. 2019 May;15(5):256-257. IF 24,646

Cardiac safety and potential efficacy: two reasons for considering minocycline in place of azithromycin in COVID-19 management.
Diana G, Strollo R, Diana D, Strollo M, Galassi AR, Crea F.
Eur Heart J Cardiovasc Pharmacother. 2020 May 7:pvaa049. IF 6.696

Managing fragility fractures during the COVID-19 pandemic.
Napoli N, Elderkin AL, Kiel DP, Khosla S.
Nat Rev Endocrinol. 2020 Jun 11:1-2. IF 24,646

Laser Ablation Versus Radiofrequency Ablation for Benign Non-Functioning Thyroid Nodules: Six-Month Results of a Randomized, Parallel, Open-Label, Trial (LARA Trial).
Cesareo R, Pacella CM, Pasqualini V, Campagna G, Iozzino M, Gallo A, Lauria Pantano A, Cianni R, Pedone C, Pozzilli P, Taffon C, Crescenzi A, Manfrini S, Palermo A.
Thyroid. 2020 Jun;30(6):847-856. IF 7.786

Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths.
Strollo R, Maddaloni E, Dauriz M, Pedone C, Buzzetti R, Pozzilli P.
Diabetes Res Clin Pract. 2021 Jan;171:108444. doi: 10.1016/j.diabres.2020.108444. Epub 2020 Sep 16.PMID: 32946854 IF 8.180

Risk of cardiac autonomic neuropathy in latent autoimmune diabetes in adults is similar to type 1 diabetes and lower compared to type 2 diabetes: A cross-sectional study.
Maddaloni E, Moretti C, Del Toro R, Sterpetti S, Ievolella MV, Arnesano G, Strollo R, Briganti SI, D’Onofrio L, Pozzilli P, Buzzetti R.
Diabet Med. 2021 Feb;38(2):e14455. doi: 10.1111/dme.14455. Epub 2020 Nov 23.PMID: 33170958 IF 4.359

Dapagliflozin as an Adjunct Therapy to Insulin in Patients with Type 1 Diabetes Mellitus: Efficacy and Safety of this Combination.
Jendle JH, Ampudia-Blasco FJ, Füchtenbusch M, Pozzilli P.
touchREV Endocrinol. 2021 Apr;17(1):12-20. doi: 10.17925/EE.2021.17.1.12. Epub 2021 Apr 28.PMID: 35118442 Review. 

Growth and development of islet autoimmunity and type 1 diabetes in children genetically at risk.
Nucci AM, Virtanen SM, Cuthbertson D, Ludvigsson J, Einberg U, Huot C, Castano L, Aschemeier B, Becker DJ, Knip M, Krischer JP; TRIGR Investigators.
Diabetologia. 2021 Apr;64(4):826-835. doi: 10.1007/s00125-020-05358-3. Epub 2021 Jan 21.PMID: 33474583 IF 10.460

Blood Glucose Level Forecasting on Type-1-Diabetes Subjects during Physical Activity: A Comparative Analysis of Different Learning Techniques.
De Paoli B, D’Antoni F, Merone M, Pieralice S, Piemonte V, Pozzilli P.
Bioengineering (Basel). 2021 May 26;8(6):72. doi: 10.3390/bioengineering8060072.PMID: 34073433 IF 4.486

Laser Ablation Versus Radiofrequency Ablation for Thyroid Nodules: 12-Month Results of a Randomized Trial (LARA II Study).
Cesareo R, Manfrini S, Pasqualini V, Ambrogi C, Sanson G, Gallo A, Pozzilli P, Pedone C, Crescenzi A, Palermo A.
J Clin Endocrinol Metab. 2021 May 13;106(6):1692-1701. doi: 10.1210/clinem/dgab102.PMID: 33608728 Clinical Trial. IF 5.958

Usefulness of Color Doppler Ultrasonography in the Risk Stratification of Thyroid Nodules.
Maddaloni E, Briganti SI, Crescenzi A, Beretta Anguissola G, Perrella E, Taffon C, Palermo A, Manfrini S, Pozzilli P, Lauria Pantano A.
Eur Thyroid J. 2021 Jul;10(4):339-344. doi: 10.1159/000509325. Epub 2020 Aug 19.PMID: 34395306 IF 4.209

Association of bone biomarkers with advanced atherosclerotic disease in people with overweight/obesity.
Del Toro R, Cavallari I, Tramontana F, Park K, Strollo R, Valente L, De Pascalis M, Grigioni F, Pozzilli P, Buzzetti R, Napoli N, Maddaloni E.
Endocrine. 2021 Aug;73(2):339-346. doi: 10.1007/s12020-021-02736-8. Epub 2021 May 4.PMID: 33948786 IF 3.633

The Mediterranean diet increases glucagon-like peptide 1 and oxyntomodulin compared with a vegetarian diet in patients with type 2 diabetes: A randomized controlled cross-over trial.
Di Mauro A, Tuccinardi D, Watanabe M, Del Toro R, Monte L, Giorgino R, Rampa L, Rossini G, Kyanvash S, Soare A, Rosati M, Piccoli A, Napoli N, Fioriti E, Pozzilli P, Khazrai YM, Manfrini S.
Diabetes Metab Res Rev. 2021 Sep;37(6):e3406. doi: 10.1002/dmrr.3406. Epub 2020 Sep 24.PMID: 32926502 Clinical Trial. IF 8.128

The impact of type 2 diabetes on the development of tendinopathy.
Cannata F, Vadalà G, Ambrosio L, Napoli N, Papalia R, Denaro V, Pozzilli P.
Diabetes Metab Res Rev. 2021 Sep;37(6):e3417. doi: 10.1002/dmrr.3417. Epub 2020 Nov 6.PMID: 33156563 Review. IF 8.128

A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes.
Forst T, Choudhary P, Schneider D, Linetzky B, Pozzilli P.
Diabetes Metab Res Rev. 2021 Sep;37(6):e3418. doi: 10.1002/dmrr.3418. Epub 2020 Dec 1.PMID: 33098260 Review. IF 8.128

Improving clinical utility of GAD65 autoantibodies by electrochemiluminescence assay and clinical phenotype when identifying autoimmune adult-onset diabetes.
Gu Y, Jia X, Vartak T, Miao D, Dong F, Jerram ST, Rewers M, Ferrara A, Lawrence JM, Yu L, Leslie RD; Action LADA consortium and the Diabetes in Young Adults (DiYA) Study Group.
Diabetologia. 2021 Sep;64(9):2052-2060. doi: 10.1007/s00125-021-05492-6. Epub 2021 Jul 16.PMID: 34272582 IF 10.460

The SAGE study: Global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DM.
Renard E, Ikegami H, Daher Vianna AG, Pozzilli P, Brette S, Bosnyak Z, Lauand F, Peters A, Pilorget V, Jurišić-Eržen D, Kesavadev J, Seufert J, Wilmot EG.
Diabetes Metab Res Rev. 2021 Oct;37(7):e3430. doi: 10.1002/dmrr.3430. Epub 2021 Mar 2.PMID: 33369842 IF 8.128

Cosimo I de Medici and his Merseburg triad of Graves’ disease.
Pozzilli P, Nicolai L.
J Endocrinol Invest. 2021 Dec;44(12):2853-2854. doi: 10.1007/s40618-021-01610-8. Epub 2021 Jun 10.PMID: 34114197 No abstract available. IF 5.467

The use of flash glucose monitoring significantly improves glycemic control in type 2 diabetes managed with basal bolus insulin therapy compared to self-monitoring of blood glucose: A prospective observational cohort study.
Bosi E, Gregori G, Cruciani C, Irace C, Pozzilli P, Buzzetti R.
Diabetes Res Clin Pract. 2022 Jan;183:109172. doi: 10.1016/j.diabres.2021.109172. Epub 2021 Dec 6.PMID: 34883185 IF 8.180

Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery.
Tavaglione F, De Vincentis A, Bruni V, Gallo IF, Carotti S, Tuccinardi D, Spagnolo G, Ciociola E, Mancina RM, Jamialahmadi O, D’Alessio R, Bottazzi B, Manfrini S, Picardi A, Perrone G, Pozzilli P, Caricato M, Vespasiani-Gentilucci U, Romeo S.
Liver Int. 2022 Feb;42(2):374-383. doi: 10.1111/liv.15127. Epub 2021 Dec 20.PMID: 34890093 IF 8.754

Erectile dysfunction and diabetes: A melting pot of circumstances and treatments.
Defeudis G, Mazzilli R, Tenuta M, Rossini G, Zamponi V, Olana S, Faggiano A, Pozzilli P, Isidori AM, Gianfrilli D.
Diabetes Metab Res Rev. 2022 Feb;38(2):e3494. doi: 10.1002/dmrr.3494. Epub 2021 Sep 21.PMID: 34514697. Review. IF 8.128

An extra virgin olive oil-enriched chocolate spread positively modulates insulin-resistance markers compared with a palm oil-enriched one in healthy young adults: A double-blind, cross-over, randomised controlled trial.
Tuccinardi D, Di Mauro A, Lattanzi G, Rossini G, Monte L, Beato I, Spiezia C, Bravo M, Watanabe M, Soare A, Kyanvash S, Armirotti A, Bertozzi SM, Gastaldelli A, Pedone C, Khazrai YM, Pozzilli P, Manfrini S.
Diabetes Metab Res Rev. 2022 Feb;38(2):e3492. doi: 10.1002/dmrr.3492. Epub 2021 Sep 25.PMID: 34435429. Clinical Trial. IF 8.128

Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis.
Tavaglione F, Jamialahmadi O, De Vincentis A, Qadri S, Mowlaei ME, Mancina RM, Ciociola E, Carotti S, Perrone G, Bruni V, Gallo IF, Tuccinardi D, Bianco C, Prati D, Manfrini S, Pozzilli P, Picardi A, Caricato M, Yki-Järvinen H, Valenti L, Vespasiani-Gentilucci U, Romeo S.
Clin Gastroenterol Hepatol. 2022 Apr 11:S1542-3565(22)00385-8. doi: 10.1016/j.cgh.2022.03.044. Online ahead of print.PMID: 35421583 IF 13.576

Contribution of rare variants in monogenic diabetes-genes to early-onset type 2 diabetes.
Pezzilli S, Tohidirad M, Biagini T, Scarale MG, Alberico F, Mercuri L, Mannino GC, Garofolo M, Filardi T, Tang Y, Giuffrida F, Mendonca C, Andreozzi F, Baroni MG, Buzzetti R, Cavallo MG, Cossu E, D’Angelo P, De Cosmo S, Lamacchia O, Leonetti F, Morano S, Morviducci L, Penno G, Pozzilli P, Pugliese G, Sesti G, Mazza T, Doria A, Trischitta V, Prudente S.
Diabetes Metab. 2022 Apr 26;48(5):101353. doi: 10.1016/j.diabet.2022.101353. Online ahead of print.PMID: 35487478 IF 5.376

SGLT-2 Inhibitors on Top of Current Pharmacological Treatments for Heart Failure: A Comparative Review on Outcomes and Cost Effectiveness.
Cavallari I, Maddaloni E, Nusca A, Tuccinardi D, Buzzetti R, Pozzilli P, Grigioni F.
Am J Cardiovasc Drugs. 2022 May;22(3):263-270. doi: 10.1007/s40256-021-00508-3. Epub 2021 Nov 17.PMID: 34786655 Review. IF 3.571

Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetes.
Pezzilli S, Mazza T, Scarale MG, Tang Y, Andreozzi F, Baroni MG, Buzzetti R, Cavallo MG, Cossu E, D’Angelo P, De Cosmo S, Lamacchia O, Leonetti F, Morano S, Morviducci L, Penno G, Pozzilli P, Pugliese G, Sesti G, Doria A, Trischitta V, Prudente S.
Acta Diabetol. 2022 May;59(5):747-750. doi: 10.1007/s00592-021-01847-y. Epub 2022 Feb 3.PMID: 35112188 No abstract available. IF 4.280

Sex-specific effects of daily tadalafil on diabetic heart kinetics in RECOGITO, a randomized, double-blind, placebo-controlled trial.
Pofi R, Giannetta E, Feola T, Galea N, Barbagallo F, Campolo F, Badagliacca R, Barbano B, Ciolina F, Defeudis G, Filardi T, Sesti F, Minnetti M, Vizza CD, Pasqualetti P, Caboni P, Carbone I, Francone M, Catalano C, Pozzilli P, Lenzi A, Venneri MA, Gianfrilli D, Isidori AM.
Sci Transl Med. 2022 Jun 15;14(649):eabl8503. doi: 10.1126/scitranslmed.abl8503. Epub 2022 Jun 15.PMID: 35704597 Clinical Trial. IF 19.319

An Investigation through Time: What hides behind the neck of this ancient Roman woman?
Messina MV, Pozzilli P, Palermo A.
Thyroid. 2022 Jul 15. doi: 10.1089/thy.2022.0331. Online ahead of print.PMID: 35838126 IF 6.568

Unveiling a novel type 1 diabetes endotype: Opportunities for intervention.
Fiorina P, Pozzilli P.
Diabetes Metab Res Rev. 2022 Jul;38(5):e3536. doi: 10.1002/dmrr.3536. Epub 2022 May 11.PMID: 35500886 No abstract available. IF 8.128

Third dose of COVID-19 vaccine in diabetes: Relevance of good metabolic control to improve its efficacy.
Pieralice S, D’Onofrio L, Pozzilli P, Buzzetti R.
Diabetes Metab Res Rev. 2022 Jul;38(5):e3533. doi: 10.1002/dmrr.3533. Epub 2022 Apr 30.PMID: 35468252. No abstract available. IF 8.128

Development of a clinical risk score to predict death in patients with COVID-19.
Alhamar G, Maddaloni E, Al Shukry A, Al-Sabah S, Al-Haddad M, Al-Youha S, Jamal M, Almazeedi S, Al-Shammari AA, Abu-Farha M, Abubaker J, Alattar AT, AlOzairi E, Alessandri F, D’Onofrio L, Leto G, Mastroianni CM, Mignogna C, Pascarella G, Pugliese F, Ali H, Al Mulla F, Buzzetti R, Pozzilli P.
Diabetes Metab Res Rev. 2022 Jul;38(5):e3526. doi: 10.1002/dmrr.3526. Epub 2022 Mar 22.PMID: 35262260 IF 8.128

COVID-19 induced Diabetes: A novel presentation.
Chandrashekhar Joshi S, Pozzilli P.
Diabetes Res Clin Pract. 2022 Aug 6;191:110034. doi: 10.1016/j.diabres.2022.110034. Online ahead of print.PMID: 35940303. Review. IF 8.180

A beautiful image of the thyroid in an apparently healthy young boy.
Pozzilli P, Villa Giovanni CF.
J Endocrinol Invest. 2022 Aug 9. doi: 10.1007/s40618-022-01850-2. Online ahead of print.PMID: 35943721 No abstract available. IF 5.467

Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: an expert-based multidisciplinary Delphi consensus.
Di Mario C, Genovese S, Lanza GA, Mannucci E, Marenzi G, Sciatti E, Pitocco D; Expert Panel Group.
Cardiovasc Diabetol. 2022 Aug 27;21(1):164. doi: 10.1186/s12933-022-01598-2.PMID: 36030229 IF 8.372

Glycemic Variability in Subjects with Diabetes and Hypogonadism during Testosterone Replacement Treatment: A Pilot Study.

Defeudis G, Maddaloni E, Rossini G, Di Tommaso AM, Mazzilli R, Di Palma P, Pozzilli P, Napoli N.
J Clin Med. 2022 Sep 11;11(18):5333. doi: 10.3390/jcm11185333.PMID: 36142982 IF 4.964

Ladarixin, an inhibitor of the interleukin-8 receptors CXCR1 and CXCR2, in new-onset type 1 diabetes: A multicentre, randomized, double-blind, placebo-controlled trial.
Piemonti L, Keymeulen B, Gillard P, Linn T, Bosi E, Rose L, Pozzilli P, Giorgino F, Cossu E, Daffonchio L, Goisis G, Ruffini PA, Maurizi AR, Mantelli F, Allegretti M.
Diabetes Obes Metab. 2022 Sep;24(9):1840-1849. doi: 10.1111/dom.14770. Epub 2022 Jul 4.PMID: 35589610 Clinical Trial IF 6.577

Trends of glucose, lactate and ketones during anaerobic and aerobic exercise in subjects with type 1 diabetes: The ACTION-1 study.
De Ridder F, Ledeganck KJ, De Winter B, Braspenning R, Delbeke D, Renard E, Pozzilli P, Pieralice S, Vissers D, De Block C.
Diabetes Metab Res Rev. 2022 Sep;38(6):e3537. doi: 10.1002/dmrr.3537. Epub 2022 May 21.PMID: 35533265 IF 8.128

C-peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective.
Maddaloni E, Bolli GB, Frier BM, Little RR, Leslie RD, Pozzilli P, Buzzetti R.
Diabetes Obes Metab. 2022 Oct;24(10):1912-1926. doi: 10.1111/dom.14785. Epub 2022 Jun 28.PMID: 35676794 Review. IF 6.577

Proton Pump Inhibitors and Fractures in Adults: A Critical Appraisal and Review of the Literature.
Briganti SI, Naciu AM, Tabacco G, Cesareo R, Napoli N, Trimboli P, Castellana M, Manfrini S, Palermo A.
Int J Endocrinol. 2021 Jan 15;2021:8902367. doi: 10.1155/2021/8902367. eCollection 2021.PMID: 33510787 Review. IF 3.257

Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services.
Lems WF, Paccou J, Zhang J, Fuggle NR, Chandran M, Harvey NC, Cooper C, Javaid K, Ferrari S, Akesson KE;
International Osteoporosis Foundation Fracture Working Group.Osteoporos Int. 2021 Mar;32(3):399-411. doi: 10.1007/s00198-020-05804-3. Epub 2021 Jan 21.PMID: 33475820 IF 5.071

The Impact of Antiosteoporotic Drugs on Glucose Metabolism and Fracture Risk in Diabetes: Good or Bad News?
Anastasilakis AD, Tsourdi E, Tabacco G, Naciu AM, Napoli N, Vescini F, Palermo A.
J Clin Med. 2021 Mar 2;10(5):996. doi: 10.3390/jcm10050996.PMID: 33801212 Review. IF 4.964

In Men With Obesity, T2DM Is Associated With Poor Trabecular Microarchitecture and Bone Strength and Low Bone Turnover.
Vigevano F, Gregori G, Colleluori G, Chen R, Autemrongsawat V, Napoli N, Qualls C, Villareal DT, Armamento-Villareal R.
J Clin Endocrinol Metab. 2021 Apr 23;106(5):1362-1376. doi: 10.1210/clinem/dgab061.PMID: 33537757 Clinical Trial. IF 5.958

Bone fragility in patients with diabetes mellitus: A consensus statement from the working group of the Italian Diabetes Society (SID), Italian Society of Endocrinology (SIE), Italian Society of Gerontology and Geriatrics (SIGG), Italian Society of Orthopaedics and Traumatology (SIOT).
Napoli N, Incalzi RA, De Gennaro G, Marcocci C, Marfella R, Papalia R, Purrello F, Ruggiero C, Tarantino U, Tramontana F, Conte C.
Nutr Metab Cardiovasc Dis. 2021 May 6;31(5):1375-1390. doi: 10.1016/j.numecd.2021.01.019. Epub 2021 Feb 4.PMID: 33812734 Review. IF 4.222

Atypical Femur Fractures: Another Piece to the Puzzle?
Napoli N.
J Bone Miner Res. 2021 Jun;36(6):1029-1030. doi: 10.1002/jbmr.4332. Epub 2021 May 17.PMID: 34000090 No abstract available. IF 6.390

Vitamin D in the Covid-19 era: a review with recommendations from a G.I.O.S.E.G. expert panel.
Ulivieri FM, Banfi G, Camozzi V, Colao A, Formenti AM, Frara S, Lombardi G, Napoli N, Giustina A.
Endocrine. 2021 Jun;72(3):597-603. doi: 10.1007/s12020-021-02749-3. Epub 2021 May
17.PMID: 33999367 Review. IF 3.633

The Treatment Gap in Osteoporosis.
Ayub N, Faraj M, Ghatan S, Reijers JAA, Napoli N, Oei L.
J Clin Med. 2021 Jul 5;10(13):3002. doi: 10.3390/jcm10133002.PMID: 34279485 Free PMC article. Review. IF 4.964

Gain-of-Function Lrp5 Mutation Improves Bone Mass and Strength and Delays Hyperglycemia in a Mouse Model of Insulin-Deficient Diabetes.
Leanza G, Fontana F, Lee SY, Remedi MS, Schott C, Ferron M, Hamilton-Hall M, Alippe Y, Strollo R, Napoli N, Civitelli R.
J Bone Miner Res. 2021 Jul;36(7):1403-1415. doi: 10.1002/jbmr.4303. Epub 2021 May 5.PMID: 33831261 IF 6.390

Management of bone fragility in type 2 diabetes: Perspective from an interdisciplinary expert panel.
Chiodini I, Gaudio A, Palermo A, Napoli N, Vescini F, Falchetti A, Merlotti D, Eller-Vainicher C, Carnevale V, Scillitani A, Pugliese G, Rendina D, Salcuni A, Bertoldo F, Gonnelli S, Nuti R, Toscano V, Triggiani V, Cenci S, Gennari L.
Nutr Metab Cardiovasc Dis. 2021 Jul 22;31(8):2210-2233. doi: 10.1016/j.numecd.2021.04.014. Epub 2021 Apr 28.PMID: 34059385 IF 4.222

DXA-Based Bone Strain Index: A New Tool to Evaluate Bone Quality in Primary Hyperparathyroidism.
Tabacco G, Naciu AM, Messina C, Sanson G, Rinaudo L, Cesareo R, Falcone S, Manfrini S, Napoli N, Bilezikian JP, Ulivieri FM, Palermo A.
J Clin Endocrinol Metab. 2021 Jul 13;106(8):2304-2312. doi: 10.1210/clinem/dgab317.PMID: 33963754 IF 5.958

Testosterone Therapy Effects on Bone Mass and Turnover in Hypogonadal Men with Type 2 Diabetes.
Colleluori G, Aguirre L, Napoli N, Qualls C, Villareal DT, Armamento-Villareal R.
J Clin Endocrinol Metab. 2021 Jul 13;106(8):e3058-e3068. doi: 10.1210/clinem/dgab181.PMID: 33735389 IF 5.958

Current and Emerging Treatment of Osteoporosis.
Tafaro L, Napoli N.
2020 Aug 21. In: Falaschi P, Marsh D, editors.
Orthogeriatrics: The Management of Older Patients with Fragility Fractures [Internet]. 2nd edition. Cham (CH): Springer; 2021. Chapter 15. PMID: 33347216 Review.

Association of bone biomarkers with advanced atherosclerotic disease in people with overweight/obesity.
Del Toro R, Cavallari I, Tramontana F, Park K, Strollo R, Valente L, De Pascalis M, Grigioni F, Pozzilli P, Buzzetti R, Napoli N, Maddaloni E.
Endocrine. 2021 Aug;73(2):339-346. doi: 10.1007/s12020-021-02736-8. Epub 2021 May 4.PMID: 33948786 IF 3.633

The impact of type 2 diabetes on the development of tendinopathy.
Cannata F, Vadalà G, Ambrosio L, Napoli N, Papalia R, Denaro V, Pozzilli P.
Diabetes Metab Res Rev. 2021 Sep;37(6):e3417. doi: 10.1002/dmrr.3417. Epub 2020 Nov 6.PMID: 33156563 Review. IF 8.128

The Mediterranean diet increases glucagon-like peptide 1 and oxyntomodulin compared with a vegetarian diet in patients with type 2 diabetes: A randomized controlled cross-over trial.
Di Mauro A, Tuccinardi D, Watanabe M, Del Toro R, Monte L, Giorgino R, Rampa L, Rossini G, Kyanvash S, Soare A, Rosati M, Piccoli A, Napoli N, Fioriti E, Pozzilli P, Khazrai YM, Manfrini S.
Diabetes Metab Res Rev. 2021 Sep;37(6):e3406. doi: 10.1002/dmrr.3406. Epub 2020 Sep 24.PMID: 32926502 Clinical Trial. IF 8.128

Weight Loss in Patients Waiting for Total Hip Arthroplasty: Fiber-Enriched High Carbohydrate Diet Improves Hip Function and Decreases Pain before Surgery.
Cannata F, Laudisio A, Russo F, Ambrosio L, Vadalà G, Cardinale ME, Bartolomei C, Iannone G, Napoli N, Papalia R.
J Clin Med. 2021 Sep 17;10(18):4203. doi: 10.3390/jcm10184203.PMID: 34575314 IF 4.964

Bone Quality as Measured by Trabecular Bone Score in Normocalcemic Primary Hyperparathyroidism.
Naciu AM, Tabacco G, Falcone S, Incognito GG, Chiodini I, Maggi D, Pedone C, Lelli D, Bilezikian JP, Napoli N, Manfrini S, Cesareo R, Palermo A.
Endocr Pract. 2021 Oct;27(10):992-997. doi: 10.1016/j.eprac.2021.04.884. Epub 2021 May 5.PMID: 33962077 IF 3.701

Secondary prevention of fragility fractures: where do we stand during the COVID-19 pandemic?
Falchetti A, Mohseni M, Tramontana F, Napoli N.
J Endocrinol Invest. 2021 Nov;44(11):2521-2524. doi: 10.1007/s40618-021-01552-1. Epub 2021 Apr 17.PMID: 33864609 No abstract available. IF 5.467

Cognitive response to testosterone replacement added to intensive lifestyle intervention in older men with obesity and hypogonadism: prespecified secondary analyses of a randomized clinical trial.
Gregori G, Celli A, Barnouin Y, Paudyal A, Armamento-Villareal R, Napoli N, Qualls C, Villareal DT.
Am J Clin Nutr. 2021 Nov 8;114(5):1590-1599. doi: 10.1093/ajcn/nqab253.PMID: 34375393 Clinical Trial. IF 8.472

The Association of Body Mass Index with Surgical Time Is Mediated by Comorbidity in Patients Undergoing Total Hip Arthroplasty.
Cannata F, Laudisio A, Ambrosio L, Vadalà G, Russo F, Zampogna B, Napoli N, Papalia R.
J Clin Med. 2021 Nov 28;10(23):5600. doi: 10.3390/jcm10235600.PMID: 34884302 IF 4.964

Vertebral fractures and mortality risk in hospitalised patients during the COVID-19 pandemic emergency.
Battisti S, Napoli N, Pedone C, Lombardi M, Leanza G, Tramontana F, Faraj M, Agnoletti V, Verna M, Viola L, Giampalma E, Strollo R.
Endocrine. 2021 Dec;74(3):461-469. doi: 10.1007/s12020-021-02872-1. Epub 2021 Sep 16.PMID: 34529239 IF 3.633

Vitamin D: Dosing, levels, form, and route of administration: Does one approach fit all?
Bilezikian JP, Formenti AM, Adler RA, Binkley N, Bouillon R, Lazaretti-Castro M, Marcocci C, Napoli N, Rizzoli R, Giustina A.
Rev Endocr Metab Disord. 2021 Dec;22(4):1201-1218. doi: 10.1007/s11154-021-09693-7. Epub 2021 Dec 23.PMID: 34940947 Review. IF 6.514

Immuno-Endocrinology of COVID-19: The Key Role of Sex Hormones.
Tramontana F, Battisti S, Napoli N, Strollo R.
Front Endocrinol (Lausanne). 2021 Dec 2;12:726696. doi: 10.3389/fendo.2021.726696. eCollection 2021.PMID: 34925228 Review. IF 5.555

The Interaction of Acute-Phase Reaction and Efficacy for Osteoporosis After Zoledronic Acid: HORIZON Pivotal Fracture Trial.
Black DM, Reid IR, Napoli N, Ewing SK, Shiraki M, Nakamura T, Takeuchi Y, Schafer AL, Kim TY, Cauley JA.
J Bone Miner Res. 2022 Jan;37(1):21-28. doi: 10.1002/jbmr.4434. Epub 2021 Sep 28.PMID: 34585443 Clinical Trial. IF 6.390

The Immunologic Profile of Vitamin D and Its Role in Different Immune-Mediated Diseases: An Expert Opinion.
Giannini S, Giusti A, Minisola S, Napoli N, Passeri G, Rossini M, Sinigaglia L.
Nutrients. 2022 Jan 21;14(3):473. doi: 10.3390/nu14030473.PMID: 35276834 Review. IF 6.706

The Impact of Diet on Bone and Fracture Risk in Diabetes.
Faraj M, Napoli N.
Curr Osteoporos Rep. 2022 Feb;20(1):26-42. doi: 10.1007/s11914-022-00725-y. Epub 2022 Feb 24.PMID: 35201556 Review. IF 5.163

Bone fragility in diabetes: novel concepts and clinical implications.
Hofbauer LC, Busse B, Eastell R, Ferrari S, Frost M, Müller R, Burden AM, Rivadeneira F, Napoli N, Rauner M.
Lancet Diabetes Endocrinol. 2022 Mar;10(3):207-220. doi: 10.1016/S2213-8587(21)00347-8. Epub 2022 Jan 31.PMID: 35101185 Review. IF 32.069

The Potential Impact of Inducing a Restriction in Reimbursement Criteria on Vitamin D Supplementation in Osteoporotic Patients with or without Fractures.
Esposti LD, Perrone V, Sella S, Arcidiacono G, Bertoldo F, Giustina A, Minisola S, Napoli N, Passeri G, Rossini M, Giannini S; LHU Study Group.
Nutrients. 2022 Apr 29;14(9):1877. doi: 10.3390/nu14091877.PMID: 35565842 IF 6.706

Analysis of the Associations Between the Human Fecal Microbiome and Bone Density, Structure, and Strength: The Osteoporotic Fractures in Men (MrOS) Cohort.
Orwoll ES, Parimi N, Wiedrick J, Lapidus J, Napoli N, Wilkinson JE, Huttenhower C, Langsetmo L, Kiel DP.
J Bone Miner Res. 2022 Apr;37(4):597-607. doi: 10.1002/jbmr.4518. Epub 2022 Feb 27.PMID: 35119137 IF 6.390

Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS.
Anastasilakis AD, Pepe J, Napoli N, Palermo A, Magopoulos C, Khan AA, Zillikens MC, Body JJ.
J Clin Endocrinol Metab. 2022 Apr 19;107(5):1441-1460. doi: 10.1210/clinem/dgab888.PMID: 34922381 Review. IF 5.958

Response to Letter to the Editor From Taguchi: “Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS”.
Anastasilakis AD, Pepe J, Napoli N, Palermo A, Magopoulos C, Khan AA, Zillikens MC, Body JJ.
J Clin Endocrinol Metab. 2022 May 17;107(6):e2651-e2652. doi: 10.1210/clinem/dgac111.PMID: 35213729 No abstract available. IF 5.958

A novel methodological approach to simultaneously extract high-quality total RNA and proteins from cortical and trabecular bone.
Faraldi M, Mangiavini L, Conte C, Banfi G, Napoli N, Lombardi G.
Open Biol. 2022 May;12(5):210387. doi: 10.1098/rsob.210387. Epub 2022 May 4.PMID: 35506206 IF 7.124

No Evidence of Association Between Undercarboxylated Osteocalcin and Incident Type 2 Diabetes.
Babey ME, Ewing SK, Strotmeyer ES, Napoli N, Schafer AL, Vittinghoff E, Gundberg CM, Schwartz AV.
J Bone Miner Res. 2022 May;37(5):876-884. doi: 10.1002/jbmr.4519. Epub 2022 Feb 27.PMID: 35118705 IF 6.390

The Role of Antihyperglycemic Drugs and Diet on Erectile Function: Results from a Perspective Study on a Population with Prediabetes and Diabetes.
Defeudis G, Di Tommaso AM, Di Rosa C, Cimadomo D, Khazrai YM, Faggiano A, Cincione RI, Napoli N, Mazzilli R.
J Clin Med. 2022 Jun 13;11(12):3382. doi: 10.3390/jcm11123382.PMID: 35743453 IF 4.964

Efficacy of radiofrequency and laser thermal ablation in solving thyroid nodule-related symptoms and cosmetic concerns. A systematic review and meta-analysis.
Cesareo R, Egiddi S, Naciu AM, Tabacco G, Leoncini A, Napoli N, Palermo A, Trimboli P.
Rev Endocr Metab Disord. 2022 Jun 29. doi: 10.1007/s11154-022-09743-8. Online ahead of print.PMID: 35768704 Review. IF 6.514

Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data.
Nusca A, Piccirillo F, Bernardini F, De Filippis A, Coletti F, Mangiacapra F, Ricottini E, Melfi R, Gallo P, Cammalleri V, Napoli N, Ussia GP, Grigioni F.
Int J Mol Sci. 2022 Jun 30;23(13):7261. doi: 10.3390/ijms23137261.PMID: 35806265  Review. IF 6.208

Calcium Citrate Versus Calcium Carbonate in the Management of Chronic Hypoparathyroidism: A Randomized, Double-Blind, Crossover Clinical Trial.
Naciu AM, Tabacco G, Bilezikian JP, Santonati A, Bosco D, Incognito GG, Gaspa G, Manfrini S, Falchetti A, Trimboli P, Mazziotti G, Napoli N, Sanson G, Cesareo R, Vescini F, Palermo A.
J Bone Miner Res. 2022 Jul;37(7):1251-1259. doi: 10.1002/jbmr.4564. Epub 2022 Jun 24.PMID: 35466449 Clinical Trial. IF 6.390

Bone fragility in type 1 diabetes: new insights and future steps.
Napoli N, Conte C.
Lancet Diabetes Endocrinol. 2022 Jul;10(7):475-476. doi: 10.1016/S2213-8587(22)00137-1. Epub 2022 May 13.PMID: 35576954 No abstract available. IF 32.069

Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience.
Gagliardi I, Celico M, Gamberini MR, Pontrelli M, Fortini M, Carnevale A, Napoli N, Zatelli MC, Ambrosio MR.
Calcif Tissue Int. 2022 Jul;111(1):56-65. doi: 10.1007/s00223-022-00963-3. Epub 2022 Mar 4.PMID: 35243531 IF 4.333

Safety and Efficacy of PTH 1-34 and 1-84 Therapy in Chronic Hypoparathyroidism: A Meta-Analysis of Prospective Trials.
Puliani G, Hasenmajer V, Simonelli I, Sada V, Pofi R, Minnetti M, Cozzolino A, Napoli N, Pasqualetti P, Gianfrilli D, Isidori AM.
J Bone Miner Res. 2022 Jul;37(7):1233-1250. doi: 10.1002/jbmr.4566. Epub 2022 May 20.PMID: 35485213 IF 6.390

Glycemic Variability in Subjects with Diabetes and Hypogonadism during Testosterone Replacement Treatment: A Pilot Study.
Defeudis G, Maddaloni E, Rossini G, Di Tommaso AM, Mazzilli R, Di Palma P, Pozzilli P, Napoli N.
J Clin Med. 2022 Sep 11;11(18):5333. doi: 10.3390/jcm11185333.PMID: 36142982 IF 4.964

Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis.
Pantano F, Tramontana F, Iuliani M, Leanza G, Simonetti S, Piccoli A, Paviglianiti A, Cortellini A, Spinelli GP, Longo UG, Strollo R, Vincenzi B, Tonini G, Napoli N, Santini D.
J Bone Oncol. 2022 Oct 28;37:100459. doi: 10.1016/j.jbo.2022.100459. eCollection 2022 Dec.PMID: 36338920 IF 4.491

Italian Ketogenic Mediterranean Diet in Overweight and Obese Patients with Prediabetes or Type 2 Diabetes.
Ivan CR, Messina A, Cibelli G, Messina G, Polito R, Losavio F, Torre E, Monda V, Monda M, Quiete S, Casula E, Napoli N, Defeudis G.
Nutrients. 2022 Oct 18;14(20):4361. doi: 10.3390/nu14204361.PMID: 36297044 IF 6.706

Pubblicazioni 2023-2024 del Prof. Paolo Pozzilli, Presidente CISD e del Prof. Nicola Napoli, Direttore Scientifico CISD

Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetes.

Strollo R, Vinci C, Man YKS, Bruzzaniti S, Piemonte E, Alhamar G, Briganti SI, Malandrucco I, Tramontana F, Fanali C, Garnett J, Buccafusca R, Guyer P, Mamula M, James EA, Pozzilli P, Ludvigsson J, Winyard PG, Galgani M, Nissim A.

Diabetologia. 2023 Jan;66(1):132-146. doi: 10.1007/s00125-022-05812-4. PMID: 36207582  IF 10.2

Gluten-Free Diet and Metabolic Syndrome: Could Be a Not Benevolent Encounter?

Defeudis G, Massari MC, Terrana G, Coppola L, Napoli N, Migliaccio S.

Nutrients. 2023 Jan 26;15(3):627. doi: 10.3390/nu15030627. PMID: 36771334. IF 5.0

Cardio-renal-metabolic disease in primary care setting.

Ibrahim M, Ba-Essa EM, Baker J, Cahn A, Ceriello A, Cosentino F, Davies MJ, Eckel RH, Van Gaal L, Gaede P, Handelsman Y, Klein S, Leslie RD, Pozzilli P, Del Prato S, Prattichizzo F, Schnell O, Seferovic PM, Standl E, Thomas A, Tuomilehto J, Valensi P, Umpierrez GE.

Diabetes Metab Res Rev. 2024 Mar;40(3):e3755. doi: 10.1002/dmrr.3755. Epub 2023 Dec 19. PMID: 38115715. IF 6.0

Relationship between Muscle Mass, Bone Density and Vascular Calcifications in Elderly People with SARS-CoV-2 Pneumonia.

Del Toro R, Palmese F, Feletti F, Zani G, Minguzzi MT, Maddaloni E, Napoli N, Bedogni G, Domenicali M.

J Clin Med. 2023 Mar 19;12(6):2372. doi: 10.3390/jcm12062372. PMID: 36983372 IF 2.9

A sub-analysis of the SAGE study in Italy indicates good glycemic control in type 1 diabetes.

Bruttomesso D, Irace C, Pozzilli P; SAGE study group.

Nutr Metab Cardiovasc Dis. 2023 Mar;33(3):631-639. doi: 10.1016/j.numecd.2022.11.008. PMID: 36670006. IF 3.7

Exocrine Proteins Including Trypsin(ogen) as a Key Biomarker in Type 1 Diabetes.

Bakinowska L, Vartak T, Phuthego T, Taylor M, Chandler K, Jerram ST, Williams S, Feldmann M, Johnson DG, Patel KA, Williams AJK, Long AE, Leslie RD, Gillespie KM; Action LADA Consortium; BOX Study Group.

Diabetes Care. 2023 Apr 1;46(4):714-721. doi: 10.2337/dc22-1317. PMID: 36701208. IF 16.6

Oxidative Stress in Postmenopausal Women with or without Obesity.

Leanza G, Conte C, Cannata F, Isgrò C, Piccoli A, Strollo R, Quattrocchi CC, Papalia R, Denaro V, Maccarrone M, Napoli N, Sardanelli AM.

Cells. 2023 Apr 12;12(8):1137. doi: 10.3390/cells12081137. PMID: 37190046. IF 5.2

Vitamin D and malabsorptive gastrointestinal conditions: A bidirectional relationship?

Giustina A, di Filippo L, Allora A, Bikle DD, Cavestro GM, Feldman D, Latella G, Minisola S, Napoli N, Trasciatti S, Uygur M, Bilezikian JP.

Rev Endocr Metab Disord. 2023 Apr;24(2):121-138. doi: 10.1007/s11154-023-09792-7. Epub 2023 Feb 23. PMID: 36813995.  IF 8.0

Biochemical Markers of Bone Fragility in Patients With Diabetes.

Meier C, Eastell R, Pierroz DD, Lane NE, Al-Daghri N, Suzuki A, Napoli N, Mithal A, Chakhtoura M, Fuleihan GE, Ferrari S.

J Clin Endocrinol Metab. 2023 May 8:dgad255. doi: 10.1210/clinem/dgad255. Online ahead of print. PMID: 37207693 IF 5.1

DXA-based bone strain index in normocalcemic primary hyperparathyroidism.

Tabacco G, Naciu AM, Messina C, Sanson G, Rinaudo L, Cesareo R, Falcone S, Napoli N, Ulivieri FM, Palermo A.

Osteoporos Int. 2023 May;34(5):999-1003. doi: 10.1007/s00198-023-06669-y. Epub 2023 Jan 14. PMID: 36640186. IF 5.4

Biochemical Markers of Bone Fragility in Patients with Diabetes. A Narrative Review by the IOF and the ECTS.

Meier C, Eastell R, Pierroz DD, Lane NE, Al-Daghri N, Suzuki A, Napoli N, Mithal A, Chakhtoura M, El-Hajj Fuleihan G, Ferrari S.

J Clin Endocrinol Metab. 2023 May 8;108(10):e923-36. doi: 10.1210/clinem/dgad255. Online ahead of print. PMID: 37155585 IF 5.1

Post hoc analysis of a randomized, double-blind, prospective trial evaluating a CXCR1/2 inhibitor in new-onset type 1 diabetes: endo-metabolic features at baseline identify a subgroup of responders.

Sordi V, Monti P, Lampasona V, Melzi R, Pellegrini S, Keymeulen B, Gillard P, Linn T, Bosi E, Rose L, Pozzilli P, Giorgino F, Cossu E, Piemonti L.

Front Endocrinol (Lausanne). 2023 Jun 20; 14:1175640. doi: 10.3389/fendo.2023.1175640. eCollection 2023. PMID: 37409229. IF 4.6

Novel Antidiabetic Agents and Their Effects on Lipid Profile: A Single Shot for Several Cardiovascular Targets.

Piccirillo F, Mastroberardino S, Nusca A, Frau L, Guarino L, Napoli N, Ussia GP, Grigioni F.

Int J Mol Sci. 2023 Jun 15;24(12):10164. doi: 10.3390/ijms241210164. PMID: 37373310. IF 4.9

Prevaccination Glucose Time in Range Correlates with Antibody Response to SARS-CoV-2 Vaccine in Type 1 Diabetes.

Alhamar G, Briganti S, Maggi D, Viola V, Faraj M, Zannella C, Galdiero M, Franci G, Fusco C, Isgrò C, Leanza G, Malandrucco I, Spinelli A, Tramontana F, Iaria D, Tortoriello R, Pieralice S, Rosati M, Matarese G, Pozzilli P, Galgani M, Strollo R.

J Clin Endocrinol Metab. 2023 Jun 16;108(7):e474-e479. doi: 10.1210/clinem/dgad001. PMID: 36611249. IF 5.1

Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes.

Maddaloni E, Coraggio L, Amendolara R, Baroni MG, Cavallo MG, Copetti M, Cossu E, D’Angelo P, D’Onofrio L, Cosmo S, Leonetti F, Morano S, Morviducci L, Napoli N, Prudente S, Pugliese G, Park K, Holman RR, Trischitta V, Buzzetti R; SUMMER Study in Diabetes Group.

Diabetes Metab Res Rev. 2023 Jul;39(5):e3632. doi: 10.1002/dmrr.3632. Epub 2023 Mar 20. PMID: 36880127. IF 6.0

Diabetes, COVID-19, and questions unsolved.

D’Souza F, Buzzetti R, Pozzilli P.

Diabetes Metab Res Rev. 2023 Jul;39(5):e3666. doi: 10.1002/dmrr.3666. Epub 2023 May 20. PMID: 37209039.  IF 6.0

Diabetes and erectile dysfunction: The relationships with health literacy, treatment adherence, unrealistic optimism, and glycaemic control.

Defeudis G, Mazzilli R, Scandurra C, Di Tommaso AM, Cimadomo D, Strollo R, Faggiano A, Migliaccio S, Napoli N.

Diabetes Metab Res Rev. 2023 Jul;39(5):e3629. doi: 10.1002/dmrr.3629. Epub 2023 Mar 3.

PMID: 36823962. IF 6.0

Bone quality in endocrine diseases: determinants and clinical relevance.

Cianferotti L, Cipriani C, Corbetta S, Corona G, Defeudis G, Lania AG, Messina C, Napoli N, Mazziotti G.

J Endocrinol Invest. 2023 Jul;46(7):1283-1304. doi: 10.1007/s40618-023-02056-w. Epub 2023 Mar 14. PMID: 36918505. IF 3.5

The Impact of GLP-1 RAs and DPP-4is on Hospitalisation and Mortality in the COVID-19 Era: A Two-Year Observational Study.

Greco S, Monda VM, Valpiani G, Napoli N, Crespini C, Pieraccini F, Marra A, Passaro A.

Biomedicines. 2023 Aug 18;11(8):2292. doi: 10.3390/biomedicines11082292. PMID: 37626788. IF 3.9

Type 2 diabetes and Covid-19: Lessons learnt, unanswered questions and hints for the future.

Nazari P, Pozzilli P.

Diabetes Res Clin Pract. 2023 Oct;204:110896. doi: 10.1016/j.diabres.2023.110896. Epub 2023 Sep 6. PMID: 37683768. IF 7.4

Glycated haemoglobin in the first year after diagnosis of type 1 diabetes is an independent risk factor for diabetic retinopathy: The IMDIAB 25 years follow-up study.

Maddaloni E, Carlone A, Pitocco D, Leanza G, Suraci C, Altomare M, Cavallo MG, Barchetta I, Morano S, Moretti C, Coraggio L, Visalli N, Tramontana F, Schiaffini R, Crinò A, Buzzetti R, Pozzilli P; IMDIAB study group (Napoli N.). Diabetes Obes Metab. 2023 Nov;25(11):3415-3419. doi: 10.1111/dom.15213. PMID: 38014612. IF 5.7

Indices of sarcopenic obesity are important predictors of finite element analysis-derived bone strength in older adults with obesity.

Gregori G, Paudyal A, Barnouin Y, Celli A, Segoviano-Escobar MB, Armamento-Villareal R, Napoli N, Qualls C, Villareal DT.

Front Endocrinol (Lausanne). 2023 Nov 7;14:1279321. doi: 10.3389/fendo.2023.1279321. eCollection 2023. PMID: 38027147. IF 4.6

An updated algorithm for an effective choice of continuous glucose monitoring for people with insulin-treated diabetes.

Maiorino MI, Buzzetti R, Irace C, Laviola L, Napoli N, Pitocco D, Esposito K; LIVE CGM working group.

Endocrine. 2023 Nov;82(2):215-225. doi: 10.1007/s12020-023-03473-w. Epub 2023 Sep 7. PMID: 37676398. IF 2.9

Leptin as predictor of cardiovascular events and high platelet reactivity in patients undergoing percutaneous coronary intervention.

Ricottini E, Gatto L, Nusca A, Melfi R, Mangiacapra F, Albano M, Cavallaro C, Pozzilli P, Di Sciascio G, Prati F, Ussia GP, Grigioni F.

Clin Nutr ESPEN. 2023 Dec;58:104-110. doi: 10.1016/j.clnesp.2023.09.003. Epub 2023 Sep 22. PMID: 38056992. IF 2.6

Vitamin D status and supplementation before and after Bariatric Surgery: Recommendations based on a systematic review and meta-analysis.

Giustina A, di Filippo L, Facciorusso A, Adler RA, Binkley N, Bollerslev J, Bouillon R, Casanueva FF, Cavestro GM, Chakhtoura M, Conte C, Donini LM, Ebeling PR, Fassio A, Frara S, Gagnon C, Latella G, Marcocci C, Mechanick JI, Minisola S, Rizzoli R, Santini F, Shaker JL, Sempos C, Ulivieri FM, Virtanen JK, Napoli N, Schafer AL, Bilezikian JP.

Rev Endocr Metab Disord. 2023 Dec;24(6):1011-1029. doi: 10.1007/s11154-023-09831-3. Epub 2023 Sep 4. PMID: 37665480. IF 8.0

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2024.

American Diabetes Association Professional Practice Committee (Napoli N.).

Diabetes Care. 2024 Jan 1;47(Suppl 1):S52-S76. doi: 10.2337/dc24-S004. PMID: 38078591. IF 16.6

Introduction and Methodology: Standards of Care in Diabetes-2024.

American Diabetes Association Professional Practice Committee (Napoli N.).

Diabetes Care. 2024 Jan 1;47(Supplement_1):S1-S4. doi: 10.2337/dc24-SINT. PMID: 38078587. IF 16.6

Summary of Revisions: Standards of Care in Diabetes-2024.

American Diabetes Association Professional Practice Committee (Napoli N.).

Diabetes Care. 2024 Jan 1;47(Supplement_1):S5-S10. doi: 10.2337/dc24-SREV. PMID: 38078579. IF 16.6

Chronicles of progress: Celebrating 40 years of scientific excellence in diabetes.

Pozzilli P.

Diabetes Metab Res Rev. 2024 Feb;40(2):e3768. doi: 10.1002/dmrr.3768.

PMID: 38598753 No abstract available. IF 6.0

Validation in type 2 diabetes of a metabolomic signature of all-cause mortality.

Copetti M, Baroni MG, Buzzetti R, Cavallo MG, Cossu E, D’Angelo P, Cosmo S, Leonetti F, Morano S, Morviducci L, Napoli N, Prudente S, Pugliese G, Savino AF, Trischitta V.

Diabetes Metab Res Rev. 2024 Feb;40(2):e3734. doi: 10.1002/dmrr.3734. Epub 2023 Oct 15. PMID: 37839040. IF 6.0

Chrononutrition in cardiometabolic diseases: Current evidence and future perspectives.

Carbone S, Pozzilli P.

Diabetes Metab Res Rev. 2024 Feb;40(2):e3779. doi: 10.1002/dmrr.3779. PMID: 38349068. IF 6.0

Type 1 diabetes: A new vision of the disease based on endotypes.

Weston CS, Boehm BO, Pozzilli P.

Diabetes Metab Res Rev. 2024 Feb;40(2):e3770. doi: 10.1002/dmrr.3770. PMID: 38450851 Review. IF 6.0

Abdominal adipose tissue distribution assessed by computed tomography and mortality in hospitalised patients with COVID-19: a retrospective longitudinal cohort study.

Battisti S, Pedone C, Tramontana F, Napoli N, Alhamar G, Russo E, Agnoletti V, Paolucci E, Galgani M, Giampalma E, Paviglianiti A, Strollo R.

Endocrine. 2024 Mar;83(3):597-603. doi: 10.1007/s12020-023-03530-4. Epub 2023 Sep 22. PMID: 37736820. IF 2.9

Non-invasive assessment of hepatic steatosis by ultrasound-derived fat fraction in individuals at high-risk for metabolic dysfunction-associated steatotic liver disease.

Tavaglione F, Flagiello V, Terracciani F, Gallo P, Capparelli E, Spiezia C, De Vincentis A, Palermo A, Scriccia S, Galati G, Napoli N, Daniels SJ, Blau JE, Carlsson B, Khazrai YM, Incalzi RA, Picardi A, Vespasiani-Gentilucci U.

Diabetes Metab Res Rev. 2024 Mar;40(3):e3787. doi: 10.1002/dmrr.3787. PMID: 38461408. IF 6.0

Targeting the Hallmarks of Aging with Vitamin D: Starting to Decode the Myth.

Ruggiero C, Tafaro L, Cianferotti L, Tramontana F, Macchione IG, Caffarelli C, Virdis A, Ferracci M, Rinonapoli G, Mecocci P, Napoli N, Calsolaro V.

Nutrients. 2024 Mar 21;16(6):906. doi: 10.3390/nu16060906. PMID: 38542817. IF 5.0

Bone canonical Wnt signaling is downregulated in type 2 diabetes and associates with higher advanced glycation end-products (AGEs) content and reduced bone strength.

Leanza G, Cannata F, Faraj M, Pedone C, Viola V, Tramontana F, Pellegrini N, Vadalà G, Piccoli A, Strollo R, Zalfa F, Beeve AT, Scheller EL, Tang SY, Civitelli R, Maccarrone M, Papalia R, Napoli N.

Elife. 2024 Apr 10;12:RP90437. doi: 10.7554/eLife.90437. PMID: 38598270. IF 6.4

Correction: Vitamin D status and supplementation before and after Bariatric Surgery: Recommendations based on a systematic review and meta‑analysis.

Giustina A, di Filippo L, Facciorusso A, Adler RA, Binkley N, Bollerslev J, Bouillon R, Casanueva FF, Cavestro GM, Chakhtoura M, Conte C, Donini LM, Ebeling PR, Fassio A, Frara S, Gagnon C, Latella G, Marcocci C, Mechanick JI, Minisola S, Rizzoli R, Santini F, Shaker JL, Sempos C, Ulivieri FM, Virtanen JK, Napoli N, Schafer AL, Bilezikian JP.

Rev Endocr Metab Disord. 2024 Apr;25(2):447-448. doi: 10.1007/s11154-023-09837-x. PMID: 38502455. IF 8.0

LADA 30th anniversary: A growing form of diabetes with persistent unresolved questions.

Lee Jia Jia I, Buzzetti R, Leslie RD, Pozzilli P.

Diabetes Metab Res Rev. 2024 May;40(4):e3800. doi: 10.1002/dmrr.3800. PMID: 38581397 No abstract available. IF 6.0

Saxagliptin/dapagliflozin is non-inferior to insulin glargine in terms of β-cell function in subjects with latent autoimmune diabetes in adults: A 12-month, randomized, comparator-controlled pilot study.

Maddaloni E, Naciu AM, Mignogna C, Galiero R, Amendolara R, Fogolari M, Satta C, Serafini C, Angeletti S, Cavallo MG, Cossu E, Sasso FC, Buzzetti R, Pozzilli P; LADASAXADAPA study group.

Diabetes Obes Metab. 2024 May;26(5):1670-1677. doi: 10.1111/dom.15469. Epub 2024 Jan 31. PMID: 38297915 Clinical Trial. IF 5.7

Nutrition, Vitamin D, and Calcium in Elderly Patients before and after a Hip Fracture and Their Impact on the Musculoskeletal System: A Narrative Review.

Cianferotti L, Bifolco G, Caffarelli C, Mazziotti G, Migliaccio S, Napoli N, Ruggiero C, Cipriani C.

Nutrients. 2024 Jun 5;16(11):1773. doi: 10.3390/nu16111773. PMID: 38892706. IF 5.0

The Mediating Role of Kynurenine Pathway Metabolites on the Relationship Between Inflammation and Muscle Mass in Oldest-Old Men.

Hetherington-Rauth M, Johnson E, Migliavacca E, Langsetmo L, Hepple RT, Ryan TE, Ferrucci L, Breuillé D, Corthesy J, Lane NE, Feige JN, Napoli N, Tramontana F, Orwoll ES, Cawthon PM.

J Gerontol A Biol Sci Med Sci. 2024 Jul 1;79(7):glae131. doi: 10.1093/gerona/glae131. PMID: 38761087. IF 4.3

Correction: An updated algorithm for an effective choice of continuous glucose monitoring for people with insulin-treated diabetes.

Maiorino MI, Buzzetti R, Irace C, Laviola L, Napoli N, Pitocco D, Esposito K; LIVE CGM working group.

Endocrine. 2024 Jul;85(1):456-457. doi: 10.1007/s12020-023-03635-w. PMID: 38291319. IF 2.9

Combining conventional and smartphone technologies to evaluate the psychomotor status in chronic malnutrition: A cross-sectional pilot study in sub-Saharan Africa.

Marano M, Todisco A, Fattori S, Valente MS, Di Loreto MV, Fantozzi IC, Albergo G, Nusca A, Napoli N, Di Lazzaro V.

J Clin Neurosci. 2024 Jul;125:141-145. doi: 10.1016/j.jocn.2024.05.031. Epub 2024 May 28. PMID: 38810411. IF 1.8

High-fiber diet reduces bone formation but does not affect bone microarchitecture in type 2 diabetes individuals.

Faraj M, Leanza G, Krug J, Cannata F, Viola V, Zampogna B, Russo F, Banfi G, Lombardi G, Vadalà G, Mangiavini L, Papalia R, Denaro V, Busse B, Napoli N.

JBMR Plus. 2024 Aug 16;8(10):ziae111. doi: 10.1093/jbmrpl/ziae111. eCollection 2024 Oct. PMID: 39253598. IF 2.4

Impact of osteoporosis and osteoporosis medications on fracture healing: a narrative review.

Chandran M, Akesson KE, Javaid MK, Harvey N, Blank RD, Brandi ML, Chevalley T, Cinelli P, Cooper C, Lems W, Lyritis GP, Makras P, Paccou J, Pierroz DD, Sosa M, Thomas T, Silverman S; Fracture Working Group of the Committee of Scientific Advisors of the International Osteoporosis Foundation, on behalf of the International Osteoporosis Foundation, Société Internationale de Chirurgie Orthopédique et de Traumatologie (Napoli N.).

Osteoporos Int. 2024 Aug;35(8):1337-1358. doi: 10.1007/s00198-024-07059-8. Epub 2024 Apr 8. PMID: 38587674. IF 5.4

Rethinking weight loss treatments as cardiovascular medicine in obesity, a comprehensive review.

Tuccinardi D, Watanabe M, Masi D, Monte L, Meffe LB, Cavallari I, Nusca A, Maddaloni E, Gnessi L, Napoli N, Manfrini S, Grigioni F.

Eur J Prev Cardiol. 2024 Aug 9;31(10):1260-1273. doi: 10.1093/eurjpc/zwae171. PMID: 38833329. IF 7.5

Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies.

Birtolo MF, Pedersini R, Palermo A, Vena W, Morenghi E, Cristofolini G, Presciuttini B, Tabacco G, Naciu AM, Pigni S, Laganà M, Mazzoleni F, Cosentini D, Ciafardini A, Pagani M, Farina D, Balzarini L, Zambelli A, Torrisi R, Cianferotti L, Napoli N, Bossi AC, Lania AG, Berruti A, Mazziotti G.

Eur J Endocrinol. 2024 Aug 5;191(2):117-125. doi: 10.1093/ejendo/lvae086. PMID: 39056237. IF 5.2

Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows.

Giustina A, Bilezikian JP, Adler RA, Banfi G, Bikle DD, Binkley NC, Bollerslev J, Bouillon R, Brandi ML, Casanueva FF, di Filippo L, Donini LM, Ebeling PR, Fuleihan GE, Fassio A, Frara S, Jones G, Marcocci C, Martineau AR, Minisola S, Napoli N, Procopio M, Rizzoli R, Schafer AL, Sempos CT, Ulivieri FM, Virtanen JK.

Endocr Rev. 2024 Sep 12;45(5):625-654. doi: 10.1210/endrev/bnae009. IF 22

Modern views of nutritional support in patients undergoing allogeneic stem cell transplantation.

Paviglianiti A, Bianchessi A, Avenoso D, Radici V, Domingo MP, Pozzilli P, Sureda A.

Clin Nutr ESPEN. 2024 Oct;63:400-408. doi: 10.1016/j.clnesp.2024.07.002. Epub 2024 Jul 4. PMID: 38971406 Review. IF 2.6

Type 2 diabetes in children and adolescents: Challenges for treatment and potential solutions.

Lee Jia Jia I, Zampetti S, Pozzilli P, Buzzetti R.

Diabetes Res Clin Pract. 2024 Nov;217:111879. doi: 10.1016/j.diabres.2024.111879. Epub 2024 Oct 5. PMID: 39369858 Review. IF 7.4

More Rapid Bone Mineral Density Loss in Older Men With Diabetes: The Osteoporotic Fractures in Men (MrOS) Study.

Tramontana F, Napoli N, Litwack-Harrison S, Bauer DC, Orwoll ES, Cauley JA, Strotmeyer ES, Schwartz AV.

J Clin Endocrinol Metab. 2024 Nov 18;109(12):e2283-e2290. doi: 10.1210/clinem/dgae045. PMID: 38407631. IF 5.1

Beyond the insulin pump: Unraveling diabetes tech dependency.

Feliziani E, Caterina Chios M, Pozzilli P.

Diabetes Res Clin Pract. 2024 Nov;217:111896. doi: 10.1016/j.diabres.2024.111896. Epub 2024 Oct 19. PMID: 39433215 Review. IF 7.4